XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net income $ 11,521 $ 9,288
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,103 1,610
Net amortization of premiums on securities 528 671
Provision for loan losses 1,193 2,949
Share-based compensation 182 302
Deferred income tax expense (benefit) 951 (2,691)
Proceeds from sale of loans held for sale 5,992 5,389
Originations of loans held for sale (5,011) (4,098)
Income on company owned life insurance (410) (450)
Net gain on sale of loans held for sale (182) (96)
Net loss (gain) on investment securities 53  
Net gain on other assets (49) (3)
Decrease (increase) in other assets 1,471 7,587
Increase (decrease) in other liabilities (2,984) (3,351)
Net cash provided by operating activities 15,358 17,107
Cash flows from investing activities:    
Purchases of available for sale securities (7,681)  
Purchases of held to maturity securities (4,466) (2,767)
Proceeds from principal payments, maturities and calls on available for sale securities 25,390 6,167
Proceeds from principal payments, maturities and calls on held to maturity securities 12,842 16,883
Proceeds from sales of securities available for sale 4,948  
Net loan originations (24,361) (60,644)
Purchases of company owned life insurance, net of proceeds received (24) (7)
Proceeds from sales of other assets 250 24
Purchases of premises and equipment (575) (383)
Net cash provided by (used in) investing activities 6,323 (40,727)
Cash flows from financing activities:    
Net increase in deposits 141,930 169,835
Net decrease in short-term borrowings (182,200) (118,600)
Purchases of common stock for treasury (193) (113)
Proceeds from stock options exercised   76
Cash dividends paid to common and preferred shareholders (4,187) (3,859)
Net cash (used in) provided by financing activities (44,650) 47,339
Net (decrease) increase in cash and cash equivalents (22,969) 23,719
Cash and cash equivalents, beginning of period 102,755 99,195
Cash and cash equivalents, end of period $ 79,786 $ 122,914